Health Condition

Tardive Dyskinesia

  • Vitamin E

    Vitamin E has been shown to reduce the severity of tardive dyskinesia.

    Dose:

    1,600 IU daily
    Vitamin E
    ×

    Vitamin E has been found in a number of studies to reduce the severity of TD. In a double-blind trial, people with TD were randomly assigned to receive vitamin E (800 IU per day for two weeks and 1,600 IU per day thereafter) or a placebo. Vitamin E was significantly more effective than placebo in reducing involuntary movements.1 An uncontrolled study of 20 people with TD reported that 1,600 IU of vitamin E per day may be the optimal amount;2 this large amount should be supervised by a healthcare practitioner. Other studies have also found that vitamin E supplements reduce the severity of TD.3,4,5 Two studies failed to show a beneficial effect of vitamin E.6,7 However, the people in those studies had been receiving neuroleptics for at least ten years, and research has shown that vitamin E is most effective when started within the first five years of neuroleptic treatment.8,9

  • Ginkgo

    Ginkgo biloba extract EGb 761 improved symptoms of tardive dyskinesia by about 30% in schizophrenic patients.

    Dose:

    240 mg daily
    Ginkgo
    ×
    In a double-blind trial, treatment with Ginkgo biloba extract EGb 761 (240 mg per day) for 12 weeks significantly improved symptoms of tardive dyskinesia by about 30% in schizophrenic patients.10 Ginkgo is believed to work by functioning as an antioxidant.
  • Lecithin (Phosphatidyl Choline)

    Lecithin and phosphatidyl choline may help improve symptoms.

    Dose:

    25 grams lecithin twice a day, providing 35 grams of phosphatidyl choline per day
    Lecithin (Phosphatidyl Choline)
    ×
     

    Choline and lecithin have both been used for people with TD. While some studies have shown a beneficial effect,11,12,13 others have reported variable improvement14 or no improvement.15 In a small, two-week, double-blind trial, people with TD were given 25 grams of lecithin twice a day (providing 35 grams of phosphatidyl choline per day), or a matching placebo. All participants experienced significant improvement of symptoms.16

  • Manganese

    Supplementing with manganese may prevent onset or help reverse the condition.

    Dose:

    For prevention: 15 mg daily while taking anti-psychotic medication; treat under a doctor's supervision: 60 mg daily
    Manganese
    ×
     

    One doctor has found that administering the trace mineral manganese (15 mg per day) can prevent the development of TD and that higher amounts (up to 60 mg per day) can reverse TD that has already developed.17 Other researchers have reported similar improvements with manganese.18,19

  • Melatonin

    Taking melatonin may help reduce abnormal movements.

    Dose:

    Take under medical supervision: 10 mg daily at bedtime
    Melatonin
    ×
     

    In a double-blind trial, supplementation with 10 mg of melatonin each night for six weeks reduced abnormal movements by 23.8% in patients with TD, compared with 8.4% in the placebo group, a statistically significant difference.20

  • Branched-Chain Amino Acids

    Supplementing with branched-chain amino acids may reduce excess phenylalanine in people with tardive dyskinesia.

    Dose:

    Refer to label instructions
    Branched-Chain Amino Acids
    ×
     

    Preliminary research has linked TD to the inability of the body to metabolize the amino acid phenylalanine. Supplementing with branched-chain amino acids (BCAA), including valine, isoleucine, and leucine, could reduce excess phenylalanine in people with this disorder. In one trial, researchers examined the effects of BCAA supplementation in people with TD (from 150 mg per 2.2 pounds body weight, up to 209 mg per 2.2 pounds body weight) after breakfast and one hour before lunch and dinner for two weeks.21 The BCAA mixture included equal parts valine and isoleucine plus 33% more leucine than either of the other two amino acids. Of nine people treated, six experienced at least a 58% reduction in symptoms, and all nine had a least a 38% decrease.

  • DMAE

    Taking dimethylaminoethanol may help reduce symptoms.

    Dose:

    Refer to label instructions
    DMAE
    ×
     

    Dimethylaminoethanol (DMAE) is a natural choline precursor. Although some preliminary data suggested that DMAE could decrease TD symptoms,22 most studies show that DMAE is no more effective than placebo for TD.23

  • Evening Primrose Oil

    Several people have experienced improvement while taking evening primrose oil.

    Dose:

    Refer to label instructions
    Evening Primrose Oil
    ×
     

    Several people have experienced an improvement in TD while taking evening primrose oil (EPO).24 In a double-blind study, however, supplementing with EPO (12 capsules per day) resulted only in a minor, clinically insignificant improvement.25

  • L-Tryptophan

    Animal research and preliminary human reports suggest that L-tryptophan may help  reduce the severity of symptoms.

    Dose:

    Refer to label instructions
    L-Tryptophan
    ×

    Animal research and preliminary human reports suggest that L-tryptophan may be helpful for reducing the severity of tardive dyskinesia symptoms.26,27,28 Typical supplementation has begun with 2 grams per day of L-tryptophan, increasing to as much as eight grams per day, sometimes accompanied by a low-protein, high-carbohydrate diet and 25 mg/day of niacin (nicotinic acid).28

  • Vitamin B3 (Niacin)

    In some studies, taking vitamin B3 as niacin or niacinamide, along with other nutrients, appeared to prevent the development of tardive dyskinesia.

    Dose:

    Refer to label instructions
    Vitamin B3 (Niacin)
    ×
     

    During a ten-year period, doctors at the North Nassau Mental Health Center in New York treated approximately 11,000 people with schizophrenia with a megavitamin regimen that included vitamin C (up to 4 grams per day), vitamin B3—either as niacin or niacinamide—(up to 4 grams per day), vitamin B6 (up to 800 mg per day), and vitamin E (up to 1,200 IU per day). During that time, not a single new case of TD was seen, even though many of the people were taking neuroleptic drugs.29 Another psychiatrist who routinely used niacinamide, vitamin C, and vitamin B-complex over a 28-year period rarely saw TD develop in her patients.30 Further research is needed to determine which nutrients or combinations of nutrients were most important for preventing TD. The amounts of niacinamide and vitamin B6 used in this research may cause significant side effects and may require monitoring by a doctor.

  • Vitamin B6

    In some studies, taking vitamin B6 along with other nutrients appeared to prevent the development of tardive dyskinesia.

    Dose:

    Refer to label instructions
    Vitamin B6
    ×
     

    During a ten-year period, doctors at the North Nassau Mental Health Center in New York treated approximately 11,000 people with schizophrenia with a megavitamin regimen that included vitamin C (up to 4 grams per day), vitamin B3—either as niacin or niacinamide—(up to 4 grams per day), vitamin B6 (up to 800 mg per day), and vitamin E (up to 1,200 IU per day). During that time, not a single new case of TD was seen, even though many of the people were taking neuroleptic drugs.31 Another psychiatrist who routinely used niacinamide, vitamin C, and vitamin B-complex over a 28-year period rarely saw TD develop in her patients.32 Further research is needed to determine which nutrients or combinations of nutrients were most important for preventing TD. The amounts of niacinamide and vitamin B6 used in this research may cause significant side effects and may require monitoring by a doctor.

  • Vitamin B-Complex

    In some studies, taking vitamin B-complex along with other nutrients appeared to prevent the development of tardive dyskinesia.

    Dose:

    Refer to label instructions
    Vitamin B-Complex
    ×
     

    During a ten-year period, doctors at the North Nassau Mental Health Center in New York treated approximately 11,000 people with schizophrenia with a megavitamin regimen that included vitamin C (up to 4 grams per day), vitamin B3—either as niacin or niacinamide—(up to 4 grams per day), vitamin B6 (up to 800 mg per day), and vitamin E (up to 1,200 IU per day). During that time, not a single new case of TD was seen, even though many of the people were taking neuroleptic drugs.33 Another psychiatrist who routinely used niacinamide, vitamin C, and vitamin B-complex over a 28-year period rarely saw TD develop in her patients.34 Further research is needed to determine which nutrients or combinations of nutrients were most important for preventing TD. The amounts of niacinamide and vitamin B6 used in this research may cause significant side effects and may require monitoring by a doctor.

  • Vitamin C

    In some studies, taking vitamin C along with other nutrients appeared to prevent the development of tardive dyskinesia

    Dose:

    Refer to label instructions
    Vitamin C
    ×
     

    During a ten-year period, doctors at the North Nassau Mental Health Center in New York treated approximately 11,000 people with schizophrenia with a megavitamin regimen that included vitamin C (up to 4 grams per day), vitamin B3—either as niacin or niacinamide—(up to 4 grams per day), vitamin B6 (up to 800 mg per day), and vitamin E (up to 1,200 IU per day). During that time, not a single new case of TD was seen, even though many of the people were taking neuroleptic drugs.35 Another psychiatrist who routinely used niacinamide, vitamin C, and vitamin B-complex over a 28-year period rarely saw TD develop in her patients.36 Further research is needed to determine which nutrients or combinations of nutrients were most important for preventing TD. The amounts of niacinamide and vitamin B6 used in this research may cause significant side effects and may require monitoring by a doctor.

What Are Star Ratings
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

References

1. Adler LA, Peselow E, Rotrosen J, et al. Vitamin E treatment of tardive dyskinesia. Am J Psychiatry 1993;150:1405-7.

2. Hashim S, Sajjad A. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses. Int Clin Psychopharmacol 1988;13:147-55.

3. Sajjad SHA. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses. Int Clin Psychopahrmacol 1998;13:147-55.

4. Elkashef AM, Ruskin PE, Bacher N, Barrett D. Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry 990;147:505-6.

5. Lohrr JB, Cadet JL, Lohr MA. Alpha-tocopherol in tardive dyskinesia. Lancet 1987;1:913-4.

6. Shriqui CL, Bradwejn J, Annable L, Jones BD. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Am J Psychiatry 1992;149:391-3.

7. Dorevitch A, Kalian M, Shlafman M, Lerner V. Treatment of long-term tardive dyskinesia with vitamin E. Biol Psychiatry 1997;41:114-6.

8. Egan MF, Hyde TH, Albers GW, et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992;149:773-7.

9. Lohr JB, Caligiuri MP. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 1996;57:167-73.

10. Zhang W-F, Tan Y-L, Zhang X-Y, RCK Chan, et al. Extract of Ginkgo biloba Treatment for Tardive Dyskinesia in Schizophrenia J Clin Psychiatry 2011;72:615-21.

11. Davis KL, Hollister LE, Barchas JD, Berger PA. Choline in tardive dyskinesia and Huntington's disease: preliminary results from a pilot study. Life Sci 1976;19:1507-15.

12. Gelenberg AJ, Doller-Wojcik JC, Growdon JH. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry 1979;136:772-6.

13. Growdon JH, Hirsch MJ, Wurtman RJ, Wiener W. Oral choline administration to patients with tardive dyskinesia. N Engl J Med 1977;297:524-7.

14. Nasrallah HA, Dunner FJ, Smith RE, et al. Variable clinical response to choline in tardive dyskinesia. Psychol Med 1984;14:697-700.

15. Anderson BG, Reker D, Ristich M, et al. Lecithin treatment of tardive dyskinesia—a progress report. Psychopharmacol Bull 1982;18:87-8.

16. Jackson IV, Nuttall EA, Perez-Cruet J. Treatment of tardive dyskinesia with lecithin. Am J Psychiatr 1979;136:1458-60.

17. Kunin RA. Manganese in dyskinesias. Am J Psychiatry 1976;133:105.

18. Norris JP, Sams RE. More on the use of manganese in dyskinesia. Am J Psychiatry 1997;134:1448.

19. Hoffer A. Tardive dyskinesia treated with manganese. Can Med Assoc J 1977;117:859.

20. Shamir E, Barak Y, Shalman I, et al. Melatonin treatment for tardive dyskinesia. A double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry 2001;58:1049-52.

21. Richardson MA, Bevans ML, Weber JB, et al. Branched chain amino acids decrease tardive dyskinesia symptoms. Psychopharmacology 1999;143:358-64.

22. Casey DE, Denney D. Dimethylaminoethanol in tardive dyskinesia. N Engl J Med 1974;291:797 [letter].

23. Soares, KV, McGrath JJ. The treatment of tardive dyskinesia-a systematic review and meta-analysis. Schizophr Res 1999;39:1-16 [review].

24. Vaddadi KS. Essential fatty acids and neuroleptic drug-associated tardive dyskinesia: preliminary clinical observations. IRCS Med Sci 1984;12:678.

25. Vaddadi KS, Courtney P, Gilleard CJ, et al. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Res 1989;27:313-23.

26. Kozell L, Sandyk R, Wagner GC, Fisher H. The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. Life Sci 1987;41:1739-44.

27. Sandyk R, Bamford CR, Khan I, Fisher H. L-tryptophan in neuroleptic-induced tardive dyskinesia. Int J Neurosci 1988;42:127-30.

28. Sandyk R, Consroe PF, Iacono RP. L-tryptophan in drug-induced movement disorders with insomnia. N Engl J Med 1986;314:1257.

29. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5-8.

30. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

31. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5-8.

32. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

33. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5-8.

34. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

35. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5-8.

36. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.